This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Background:Medical comorbidities and stroke risk factors only explain a proportion of stroke incidence and outcomes in different populations. The primary outcome measure was ambulatory status at discharge, defined as ability to ambulate with or without the assistance of a device or person. 0.96],p=0.001).Patients 1.18];P=0.001).
Established by the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) , the MIPS Program is pivotal in determining Medicare payment adjustments for healthcare practices. Contact us today to schedule a demo to take the first step towards optimizing your MIPS reporting and improving outcomes for your patients. What is MIPS?
The 2024 payment adjustment is important to compensation for Medicaid services provided. Report 6 measures, including one Outcome or other High Priority measure for 12 months on at least 70% of eligible encounters to receive a score based on 2023 National Benchmarks. For a minimum of 90 days, report all required measures.
Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. In 2020, patients had higher odds of initiating LAAO use than in 2015 (0.52 0.68]) versus White race, and Medicaid eligibility (aOR, 0.61 [95% CI, 0.58–0.64]) versus 9.32%; adjusted odds ratio [aOR], 13.64 [95% CI, 12.56–14.81]).
We examined the demographic and clinical correlates of EVT use in CVT and assessed its impact on patient outcomes utilizing a national database.MethodsWe identified CVT cases from 2015 to 2020 in the National Inpatient Sample, with EVT as the primary exposure. 0.59, p<0.001) or Medicaid insurance (OR: 0.70, 95% CI: 0.50‐0.99,
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
40 
Let's personalize your content